Prevalence of thyroid diseases in patients with acromegaly: results of an Italian Multi-center Study

被引:99
作者
Gasperi, M
Martino, E
Manetti, L
Arosio, M
Porretti, S
Faglia, G
Mariotti, S
Colao, AM
Lombardi, G
Baldelli, R
Camanni, F
Liuzzi, A
机构
[1] Univ Pisa, Dept Endocrinol, Pisa, Italy
[2] Univ Milan, Osped Maggiore, IRCCS, Inst Endocrinol Sci, Milan, Italy
[3] Univ Cagliari, Inst Internal Med, Cagliari, Italy
[4] Univ Naples Federico II, Dept Endocrinol & Clin & Mol Oncol, Naples, Italy
[5] Univ Roma La Sapienza, Dept Clin Sci, Endocrinol Sect, Rome, Italy
[6] Univ Turin, Inst Internal Med, Div Endocrinol, Turin, Italy
[7] Osped San Giuseppe, IRCCS, Auxol Italian Inst, Div Endocrinol, Verbania, Italy
关键词
acromegaly; thyroid diseases; goiter; IGF-I; TSH;
D O I
10.1007/BF03343997
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acromegaly is frequently associated with the presence of thyroid disorders, however the exact prevalence is still controversial. An Italian multicenter study was performed on 258 patients with active acromegaly (high levels of IGF-I and lack of suppression of serum GH levels below 2 mug/l after an OGTT). The control group was represented by 150 patients affected by non-functioning and PRL-secreting pituitary adenomas. Two hundred and two out of 258 acromegalic patients (78%) were affected by thyroid disorders with a significantly higher prevalence with respect to the control group (27%, p<0.0001). One hundred and three patients presented (39.9%) non-toxic nodular goiter, 46 (17.8%) non-toxic diffuse goiter, 37 (14.3%) toxic nodular goiter, 1 toxic diffuse goiter (0.4%),12 (4.6%) Hashimoto's thyroiditis, 3 (1.2%) thyroid cancer. Two patients presented a co-secreting TSH pituitary adenoma. Thirty-six patients had been previously treated for various thyroid abnormalities. Among the 222 acromegalic patients never treated for thyroid disorders thyroid ultrasonography was performed on 194 subjects. Thyroid volume in patients with thyroid abnormalities was 28+/-17.5 ml (median 23) while it was 10.8+/-3.6 ml (median 10) in patients without thyroid disorders (p<0.0001). Thyroid volume was correlated with the estimated duration of acromegaly (r=0.7, p<000.1), but not with age or with serum GH, IGF-I and TSH concentrations. Thyroid volume was higher in acromegalic patients than in the above control population (23.5+/-16.9 ml vs 13.9+/-12.8 ml, p<0.0001). In 62 acromegalic patients 101 fine-needle biopsies of thyroid nodules were performed; 7 nodules were suspicious and the patients were submitted to thyroid surgery: papillary thyroid carcinoma was found in 3 patients. In conclusion, in a large series of acromegalic patients an increased prevalence of thyroid disorders (78%), particularly non-toxic nodular goiter, has been observed. Thyroid volume, evaluated by ultrasonography, was correlated to the estimated duration of acromegaly. Finally, the prevalence of thyroid carcinoma was slightly increased than in the general population.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 35 条
[1]   The spectrum of thyroid disorders in an iodine-deficient community: The Pescopagano survey [J].
Aghini-Lombardi, F ;
Antonangeli, L ;
Martino, E ;
Vitti, P ;
Maccherini, D ;
Leoli, F ;
Rago, T ;
Grasso, L ;
Valeriano, R ;
Balestrieri, A ;
Pinchera, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :561-566
[2]   EFFECTS OF TREATMENT WITH OCTREOTIDE IN ACROMEGALIC PATIENTS - A MULTICENTER ITALIAN STUDY [J].
AROSIO, M ;
MACCHELLI, S ;
ROSSI, CM ;
CASATI, G ;
BIELLA, O ;
FAGLIA, G ;
MARTINO, E ;
SQUATRITO, S ;
GIUSTI, M ;
CANNAVO, S ;
VELARDO, A ;
SICOLO, N ;
BARBARINO, A ;
TAMBURRANO, G ;
CICCARELLI, E .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 133 (04) :430-439
[3]   AN ASSOCIATION BETWEEN ACROMEGALY AND THYROID-CARCINOMA [J].
BALKANY, C ;
CUSHING, GW .
THYROID, 1995, 5 (01) :47-50
[4]   BENIGN AND MALIGNANT-TUMORS IN PATIENTS WITH ACROMEGALY [J].
BARZILAY, J ;
HEATLEY, GJ ;
CUSHING, GW .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (08) :1629-1632
[5]  
Brunn J, 1993, DTSCH MED J, V287, P1206
[6]   Goiter and impairment of thyroid function in acromegalic patients:: Basal evaluation and follow-up [J].
Cannavò, S ;
Squadrito, S ;
Finocchiaro, MD ;
Curtò, L ;
Almoto, B ;
Vieni, A ;
Trimarchi, F .
HORMONE AND METABOLIC RESEARCH, 2000, 32 (05) :190-195
[7]   Serum IGF-I and IGFBP-3 levels for the assessment of disease activity of acromegaly [J].
Chen, HS ;
Lin, HD .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1999, 22 (02) :98-103
[8]   Growth hormone does not increase thyroid size in the absence of thyrotropin: A study in adults with hypopituitarism [J].
Cheung, NW ;
Lou, JC ;
Boyages, SC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :1179-1183
[9]   The thyroid gland in acromegaly: An ultrasonographic study [J].
Cheung, NW ;
Boyages, SC .
CLINICAL ENDOCRINOLOGY, 1997, 46 (05) :545-549
[10]   Increased incidence of neoplasia in females with acromegaly [J].
Cheung, NW ;
Boyages, SC .
CLINICAL ENDOCRINOLOGY, 1997, 47 (03) :323-327